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Abstract 
An optimal control problem consists of two basis functions : state functions 
and control functions. The state function describes the state of the system as 
a function of time while the control function describes the input to the system, 
which can be chosen and under control. 
This paper is a study of optimal control applied to cancer chemotherapy, the 
treatment on killing the cancer cells by using drugs. In the first chapter, we 
will set up a mathematical model for the real problem, the Gompertz model is 
used to describe the tumour growth. Furthermore, there will be some detailed 
descriptions on the parameters used in the mathematical model. 
In Chapter 2, some simplifications of the model set up in Chapter 1 will be done. 
We will show the compactness of the feasible set and the existence of optimal 
solutions. In addition, we will discuss the calculations of the first derivatives and 
the second derivatives of both the objective function and constraints involved in 
the mathematical model. 
In Chapter 3, a Lagrangian multiplier algorithm and a Penalty algorithm for 
solving the constrained optimization problem together with Armijo method and 
Newton's method for solving the unconstrained optimization will be introduced. 
Moreover, a modified augmented Lagrangian algorithm will also be studied. The 
comparisons of different algorithms will be presented. 
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Chapter 1 
Background and Modelling 
1.1 Treatment of Cancer 
This paper is a study of optimal control in the area of biomedicine, the treatment 
of cancer by using drugs [1]. Our aim is to determine numerically how to get 
optimal effect on using the drugs to kill the cancer cells. 
What we are going to do is to find the drug schedule that specifies which drug is 
delivered, when and at what dose. And this drug schedule is in fact the control 
function in our mathematical models. With this drug schedule, the tumour cell 
population after a fixed period of treatment, under certain constraints about the 
drug toxicity and drug resistant, is being minimized. So, we will first set up 
the mathematical model on the cancer chemotherapy and then simulate it on a 
computer. A fundamental quantity associated with tumour growth is the doubling 
time of the tumour cell population, denoted by r . 
1.2 Tumour Growth Model — Gompertz Model 
A differential equation can be used to model the growth of the tumour cell pop-
ulation provided that the initial tumour cell population is No. 
5 
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Let N{t) be the tumour cell population at time t, N{t) be its derivative with 
respect to t, or its growth rate. 
There are three commonly used models to describe the tumour growth model: 
exponential, logistic and Gompertz. 
The exponential model of the tumour growth is given by : 
: _ = &N ( U ) 
N{0) = No 
< 
where the parameter A^ is a constant related to the doubling time of the tumour 
growth. 
Equation (1.1) has the following analytical solution : 
_ = Noe^Et. 
It has been shown that for some cancers, assuming no treatment is given, as the 
mass of tumour increases, its growth slows down [10]. Also, as time increases, 
the tumour mass approaches a stable level 0, called the plateau population. Since 
the victim may be dead if the population of the cancer cell is over a certain limit. 
Hence, the exponential growth model is not a good formulation for the tumour 
growth model as the tumour cell population grows exponentially until infinity 
when time increases to infinity. 
The logistic growth model is given by the logistic function : 
i m = x . N { i - f ) (12) 
�AT(0) = No 
and the Gompertz model is described by 
/ _ = A G _ h i ( ^ ) (1.3) 
\ N{0) = No 
where the parameters Xi and Ac are constants related to the doubling time of 
the tumour growth. 
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In a study by Michelson, by comparing the logistic and Gompertz models, the 
Gompertz equation (1.3) gave the best fit in four of five tumour cell popula-
tions [11]. Therefore we will concentrate on the Gompertz model for the tumour 
growth. 
In the Gompertz model, the parameter Xo is a positive constant which can be 
calculated from the tumour doubling time r : 
, , = i , n [ ^ ] . (1.4) T L ln (^ ) J 
Gompertz modsl 10'% 1 1 1 1 r 1 — 1 " ‘~~： 
10'2: -
i / / ^ ^ 
10 ” ： ^ ^ • 
io'"LL I I 1 1 1 1 1 ‘ ‘ ‘~ 
1U 0 5 10 15 20 25 30 35 40 45 50 Tim*in weeks 
Figure 1.1: Gompertz model are used here to simulate tumour growth. For this 
model, the initial tumour burden is 10 °^ cells and the initial tumour population 
doubling time is 4 weeks. The plateau population is 0 = 10^ ^ cells. 
1.3 Drug Concentration and Drug Effects 
Consider the bloodstream of volume c in which the drug concentration at time 
t is v{t). Suppose the drug is delivered at a rate of u{t) into the body. By 
some processes such as excretion or metabolism，the drug concentration falls by 
fi 
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fraction of 7dt over the time period of dt. The conservation of the amount of the 
drugs gives : 
cv{t + dt) = c(1 - jdt)v{t) + u(t)dt. (1.5) 
By Taylor's expansion, we have : 
v{t + dt) = v{t) + v{t)dt + 0{dt^). (1.6) 
Substituting (1.6) into (1.5), we get the following differential equation : 
r m = ^W - l < i ) (1.7) 
1 _ ) = t ^ 
where vo is always assumed to be zero. 
Here the constant c has been absorbed into u(t) by a suitable scaling. 
Suppose that dose i is delivered at a fixed time U = {i - l)At at concentration 
of Ui. Then u{t) can be expressed as : 
n 
u(t) = Z t / i 5 ( f - f 0 . (1.8) 
t=i 
By substituting equation (1.8) into the differential equation (1.7) and solving it 
analytically, we obtain 
v{t)+^v{t) =u{t) 
or equivalently 
v{t) = e-^^^^( J e^^^'u{t)dt) 




= t u i e - 7 ( f - " ) F ( t - t ) (1.9) 
i = l 
where H{.) is called the Heaviside step function. 
r 0 if t < ti H{t - U) = \ L 1 otherwise. 
a 
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1.3.1 Drug Effects on Tumour Cells 
By combining the two effects from the growth and the drugs, we have : 
iV(t) = A c i V ( t ) l n ( ^ ) - L ( i V , t ; ) (1.10) 
where L{N,v) is the cell-loss term resulting from the drug effect. 
By many clinical observations, L{N, v) is linear in N and the drugs will have 
no effect on killing the cancer cells if the concentration is lower than a specific 
amount ”th. So, the term describing the drug effects has the form : 
L{N, v) = k[v{t) - Vth]H[v{t) - Vth]N{t). (1.11) 
The parameter k is a proportional constant of tumour cells killed per unit time 
per unit drug concentration, and is assumed to be positive. This constant can be 
calculated from successive measurements of tumour volumes. 
Hence, the Gompertz model becomes : 
r N{t) = \测 M ^ ) - k[v{t) 一 vth]H[v{t) 一 t;t"]A^W ( 1 . 1 2 ) 
1 AT(0) = No. 
1.3.2 Drug Effects with Different Values of XG,k,vth 
In the Gompertz model (1.12) discussed in the preceding subsection, there are 
three important parameters involved: Ac, k and Vth- ^G is a parameter related 
to how fast the tumour cells grow, k and Vth are parameters related to the per-
formance of the drugs on killing the tumour cells. To have a better feeling of 
the effects with different parameter values on the tumour cell population, we plot 
Figure 1.2 which shows how the cell population, N{t), varies with different values 
of the parameters A^, k and Vth-
For all the four graphs, 15[D] of drugs were delivered into the body on the first 
26 weeks and 20[D] of drugs on the last 26 weeks, where [D] is the unit of drug 
concentration. The initial tumour burden No is 10 °^ cells and the initial tumour 
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population doubling time r is 165 days. The maximum tumour cell population 
Nmax is lOio cells and the plateau population 6> is 10^^  cells. 
10".~._,~~,——.~~A^~~.~".~~•~"^ i�,,j~"•~"‘""^‘~"•~"^~~‘~"‘~‘~~^ 
10,�\ 1, ^ , ^ \ ^ ^ ^ 
r ^ \ . r. 
i.o'. \ • Sio- . 
10' \ ^ 1°' 
10' \ ^ 1°‘ 10*^~~^  10 l's 2C .'s 3^  3S 丄;s s_^  "'o S 10 1S 20 _2f_: - « 妨 SO Tlrno In w09Ks 
Figure 1.2A: Ac 二 9.9 x 10"^ days_i, Figure 1.2B: Ac and vth is the same as 
k = 0.027 days-i[D]-i and Vth = 10[D]. in Graph A and k = 0.0084 days"^D]-^ e D 
10".——I—r-~.—.—.—.~^—i——n i�”f—‘—‘—‘—‘—‘—‘—‘ ‘ ‘ n 
. L _一 ....^=^^^~ 
10' • • 1°，• • 1"'- . r ' • 
1 I 
S10' • . 310', • 
10' . 10' • 
10' • . 1°'. • . , , . , I , I I L_ in' . • ‘ I 1 1 1 1 " ‘~ 10 1 to ts to ts to ts io i tr 0 S 10 15 20 25 30 36 40 45 SO Tlmelnweks Tlmeinweks 
Figure 1.2C: Ac and k is the same as Figure 1.2D: k and Vth is he same as in 
in Graph A and Vth = 30[D]. Graph A and Ac = 9.9 x 10"^ days"^ 
Effect of the parameter k : As described before, k is a parameter related to the 
performance of the drugs on killing the tumour cells. Note that in figure 1.2A, 
the parameter k is larger than that of figure 1.2B, with other parameters kept 
constant. By comparing both figures, we can see that the population of tumour 
cells drop much more faster in figure 1.2A than figure 1.2B. 
Effect of the parameter Vth : Vth is the parameter that whenever the drug con-
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centration is lower than it, the drug will cease to have a therapeutic effect. By 
comparing figure 1.2A and figure 1.2C, with the only difference on the parameter 
vtf^ , it is clear that the drug ceases to have a therapeutic effect in figure 1.2C. 
Effect of the parameter A^ : Ac is the parameter describing how fast the tumour 
cells grow. By using the drug of same quality, it is shown that the population of 
tumour cells drop much more slower in figure 1.2D, compared with figure 1.2A. 
1.4 Constraints on the Gompertz Model 
It is observed that there is some toxic side-effects of the drugs on human body. 
One measure of toxicity is the number of white blood cells. When doses of 
anti-cancer drug is delivered into the body, the white blood cell population is 
devastated. So, the drug concentration in the body must be kept bounded above 
by some positive parameter Vmax : 
0 < v{t) < Vmax foralHG[0,T]. (1.13) 
Also, the cumulative toxicity have significant side-effects on human body. So the 
total cumulative toxicity must be kept bounded above by some positive parameter 
^cum ’ 了 
[v{s)ds < Vcum- (1.14) Jo 
Moreover, it has been shown (cf. [1]) that there may be drug resistant lines and 
the proportion of drug resistant cell increases when the tumour size increases. To 
limit the tumour size, we have the following constraint : 
N{t) < N^ for all t G [0,T]. (1.15) 
• 
Chapter 2 
Minimization on the Gompertz 
Model 
2.1 Mathematical Modelling on the Gompertz 
Model 
Our aim, or the aim of the medical treatment of cancer, is to minimize the 
tumour cell population on the final state of the treatment. In the following 
sections, we are going to deal with the minimization problem on the Gompertz 
model. Summarizing the Gompertz model and realistic constraints, a complete 
mathematical model can be formulated as follows : 
min Ji{u) = N{T) (2.1) 
ueB,i 、， 
subject to : 
^ ‘ N{t) = XGN{t) l n ( ^ ) - k[v{t) 一 vth]H[v{t) - Vth]N{t) (？ � 
N{0) = No 
<. 
with drug concentration : 




Numerical Optimal Control in Cancer Chemotherapy 13 
and the constraints : 
0 < v{t) < Vmax Vt€[0,T], (2.4) 
N{t) < Nmax Vt€[0,T], (2.5) 
/ T 
v{s)ds < i;cwm. (2.6) 
Recall that all the parameters have the following medical meanings : 
N{t) : the number of cancer cells at time t. 
No : the initial tumour cells population. 
Nmax : the upper bound of tumour cells population. 
Ac : growth rate parameter related to the doubling time of the 
tumour growth. 
0 : the plateau tumour cell population. 
k ： cell-loss parameter related to the effect of the drug on killing 
tumour cells. 
v{t) : the concentration of the anti-cancer drug at time t. 
vth : the lower bound of drug concentration having therapeutic effect. 
Vmax : the maximum drug concentration. 
Vcum : the maximum cumulative drug toxicity. 
i 
Ui : the drug concentration delivered at time U = {i — l)At. 
2.1.1 Constraints Transformation 
Due to the special structure of the drug concentration v{t), the constraints (2.4) 
and (2.5) can be reduced to linear constraints and non-linear interior-point con-
straints, respectively. This is stated in the next theorem (cf. [1]). 
Theorem 1 0 < v{t) < Vmax for all t G [0, T] if and only if 0 < v{U) < Vmax, 
for i = 1,2, •. • ’ n; and iV(t) < Nmax for all t G [0，T] if and only ifN{U) < Nmax, 
fori = l，2，...,n + l. 
^ 
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Proof: Consider the function v ( t ) over each sub-interval [ t j - y t j + i ) , f 
n 
v { t ) 二 J 2 ^ e - ^ - t i ) H ( t - t i ) , t € [ t j , t j ^ i ) 
i=l 
= ; ^ n f * t " . 
i=l 
v { t ) decreases over the sub-interval [ t j , t j + i ) . That is, the maximum value o f v { t ) 
over [tj,tj+i) occurs at t 二 tj. Hence, v{t) < Vmax for all t G [tj,tj^i) if and only 
i f v { t j ) < Vmax' 
Let us now consider the differential equation (2.2) of the function N{t): 
f N{t) 二 AciV^ l n ( ^ ) - k[v{t) - vth]H[v{t) 一 Vth]N{t) 
\ 7V(0) = 7Vo. 
Over the sub-interval [tj.,tj.+i), the function N(t) is continuously differentiable. 
If N(t) has a relative maximum at t* in (tj,tj+i), it satisfies N(t*-) = 0. Also, 
N(t) is twice continuously differentiable on (tj,tj+i), with the possible exception 
of the point at which v(t) = Vth. Such a point occurs at most once in (tj,tj+i) 
since v ( t ) is decreasing over ( t j , t j + i ) . If v ( t ) < Vth, 
I ^ � t � = X G N \ n � � > 0 , 
so that N{t) cannot have a relative maximum. If v{t) > Vth, 
I 
N ( t ) = XoNit) l n ( ^ ) - X c M t ) 一 k _ - Vth)N{t) 一 k N { t ) v { t ) 
=N{t) [Ac ln (^) 一 Ac 一 k{v{t) - ^)] - kr^t)<t) 
^kN{t)^v{t), 
therefore 
N{t*) = kyvN > 0 . 
This shows that N is positive and thus N{t) has no relative maximum. Since 
N { t ) is continuous on [ t j , t j + i ] , the only possibilities are that N { t ) is maximized 
� 
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over t € [tj,tj+i] at either tj or tj+i. 口 
In practice, the first constraint N(ti) = No < N^ax and the last constraint 
N{tn^i) = N{T) < Nmax can be omitted, since the first is independent of the 
parameter vector w, and the last is already described by the objective function 
(2.1). 
Note also that if we substitute relation (2.3) into the constraint (2.6), the con-
straint may be simplified as : 
i V ^ . ( l - e - ^ ( ^ - ^ ^ ) ) < W (2.7) t^r 
2.2 Simplified Minimization Problem 
We now try to simplify the minimization problem (2.1) - (2.6). To do so, we 
introduce the following dimensionless scaling : 
y{t) = l n ( ^ ) , (2.8) 
I 
then the differential equation (2.2) becomes, ； 
r y{t) = -XGV{t) + k [v{t) - Vth]H[v{t) - vth] (2 9) 
^ y(O) = yo = l n 4 . 
Lemma 1 The differential equation (2.9) can be solved analytically and the 
solution is given by : 
y{t) = yoe_XGt + e + * f e^^'k[v{s) 一 Vth]H[v{s) 一 Vth] ds. (2.10) 
Jo 
Proof: From (2.9)，we have 
y{t) + Xcy{t) = k[v{t) - vth]H[v{t) - ^ ] , 
^ 
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so we get 
y(t) = e _ " c ^ ( J e^^^^'k[v{s) - Vth]H[v{s) - Vth] ds� 
= e _ A c i ( j^ e^^'k[v{s) 一 Vth]H[v{s) - %J ds + c; 
二 ce—XGt + e_XG* [ e^^'k[v{s) _ Vth]H[v{s) - Vth] ds. 
Jo 
By substituting y{0) = yo, we get c 二 yo, then 
y{t) = yoe—XGt + e_XGt f e^^'k[v{s) - Vth]H[v{s) 一 Vth] ds. • 
Jo 
In summary, the original minimization problem (2.1) - (2.6) can now be formu-
lated as follows : 
min^,€Rn J2{u) = -y{T) (2.11) 
subject to : gj{u) = y{tj^i) - Vmin > 0, j = l , . . . , n - l . 
3 
9j^n-l{u) 二 V ^ 一 J2 ¥-他一'0 > 0， j = 1，• •.,几. 
i=l • 
g2n{u) 二 Vcum - - ^ 2 以《(1 - 已 - 7 ( 了 - 亡 《 ） ) > 0 . : 
^ i=l 
gj+2n = Uj > 0, j = l,...,n. 
For the convenience, we will let U be the feasible region described by the above 
constraints Qj{u) > 0 for all j = 1,2’ . . . , 3n. 
2.2.1 Avoiding Non-Minimal Stationary Points 
Due to the Heaviside function on the right-hand side of the state differential 
equation (2.9), there are subsets of the interior of the feasible set U over which 
the objective function J2{u) = -y{T) is constant. Then a numerical algorithm 
can converge to a point in such a subset since at each point the conditions of a 
1 
Jb 
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local minimum hold. 
For example, if Nmax is large enough such that the constraint (2.5) is always 
satisfied. Let u = [0,0’ •. •，Of. Then, u satisfies all the constraints, and 
J2{u) = -y{T) 
=—yoe—�T + g-AoT f e^^^A;[t;(5) - vth]H[v{s) 一 Vth]ds 
Jo 
二 - m - � T . 
Let u == k e , . . . , eF with small e > 0. Then v{t) < Vth for all t G [0, T . u 
J2{u) 二 i c n ^ 
= - y Q e — X c T + e"^GT / e^^'k[v{s) 一 Vth]H[v{s) 一 Vth]ds 
Jo =1oe-AGT 
=«72(补 
Hence, {w : Ui < e , i = 1,2, • . . , n} is a subset of the interior of the feasible set 
U. Over this subset, the objective function J2{u) = -yoe'^^^ is constant. 
To avoid this non-minimal stationary points, we will add a term to the objective 
function so that it is no longer constant over such a region, and which does not 
[y significantly alter the problem. We define an augmented objective function : 
Mu) = - y { T ) - n j 2 ^ ^ (2.12) 
i=l 
where the parameter /x is positive. 
Lemma 2 J^(w) is continuous with respect to u. 
Proof: Since piYn=! ^1 i® continuous, we only need to show that y{T) is con-
tinuous with respect to u. 
We first introduce a time Sj in each time interval [tj,tj+i). The time sj in 
each time interval [tj,tj+i) is a time such that v{t) = iHh. If v{t) < Vth for 
^ 
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all t e [t,-,t,+i), let Sj == t j . If v { t ) > Vth for all t E [ t j , t j ^ i ) , let Sj 二 t ^ i . If 
v{t) 二 vtk for some t G [^,t,+i), by solving equation (2.3)，Sj can be calculated ： 
= l l n [ l f ^ ^ F / ( A - t i ) e ^ 
7 L ^ 台 J 
二 i l n [ l f ^ y . (2.13) 
7 ^^th t f 
From equation (2.10), we have 
rjn 
y{T) 二 yoe-XGT + e"AGT f e^^'k[v{s) 一 Vth]H[v{s) - Vth] ds 
Jo = y o e - ^ ^ ^ + e-^«^ x Y{u) 
where Y{u) = jJ e^^'k[v(s) - Vth]H[v{s) - Vth] ds. 
Now consider Y{u). By definition of v{s), we have 
rT Y{u) 二 / e^^'k[v{s) 一 Vth]H[v{s) - Vth] ds 
Jo 
n ftj+i 
=5^ / e^^'k[v(s) - Vth]H[v{s) - Vth] ds 
j=i Jtj 
n psj 
= ^ / ke^^'[v{s) - vth] ds 
i=i Jtj 
= J 2 r ke^^'[^Uie-^^'-*'^H{s - U) 一 一 ds 
j=i Jtj i=i 
= t r ke^^'[^Ui6-^^'-''^ - vth] ds. 
j=i Jtj i=i 
Next we prove that Sj is a continuous function of u. It is obvious that Sj is 
piecewise continuous with respect to u. In order to show that Sj is continuous, 
we only need to show that Sj is continuous at the following two cases : 
Case 1 : At u such that v{tj) = Vth. 
Case 2 : At u such that v{tj^i) = Vth. 
For case 1, at u ' , where v{tj)la- < vth and xT is very close to u. We have, 
^ ^ ^ ^ ^ ^ ^ ^ ^ — ^ ^ ^ — ^ ^ ~ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ — ^ ~ ~ " ^ ^ ~ " ^ ~ — ^ ^ ^ ~ ^ ^ ^ ~ * — ^ — " ' 
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v{tj)lu- < Vth, 
or v{t)lii- < vth, Vt € [tj,tj^i) 
thus Sj\ii- = tj. 
At w, we have v{tj) = Vth, namely 
f2^e_7h_ti) = vth, 
i=l 
SO w e g e t 
3 
Y^ me^'' = VthC^. 
i = l 
From equation (2.13), 
Si = - l n l—^Uie^*' 
7 ^^th tr � 
1 , 1 欢1 ==-ln —vthe^ 
7 L”th 
=iln[e^-7 L 
— 十. 一 ^3' 
Thus, Sj is continuous at u. 
For case 2，at u. Since v{tj+i) = vth, we know that v(t) > vth for all t £ [tj,tj+i) 
and thus Sj = tj+i. 
At u- , where ^;^+i)|n- < Vth and U— is very close to u. We have, 
lim v{tj+i)lu- = ^th: 
u~^u 
3 
lim S"u-e-^^'i+'-' '^ 二 Vth, 
^-^^tt 
3 
lim y " % - e ^ f ^ + i = Vth, u-^u^ ‘ t = l 
3 
lim Y u - e ^ ' ' 二 m e ^ + � u-^u^ t = l 
^^^—^^^^^^^^—^^^^—^^^^^^^^^—~^—^^^^^^^~~^^^^^^^^^^^^^^—'———^~'-°^'.内 
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Again, from equation (2.13), 
lim sAu- = - l n [— lim E ^ _ e ^ 
u-^u ^ 7 L^ n-^u^ � 
二 i ln l—VthC^'^+' 
7 ^ ¾ J 
= i l n [ e ^ 
7 L 
=^j+i-Thus, Sj is continuous at u. 
Hence, we know that Sj is continuous with respect to u and we now prove that 
Y{u) is continuous at any u. For any e > 0, we take 
€ 
ei — 2nke^G^[vmax 一 ^th . 
Since sj is continuous, there exists 6i > 0 such that 
Vw, II u-u ||2< ^1 and | s ) - - ^ | < e i Vj. 
By taking 
“ — k W ^， A } ’ 
for all u such that || u - u ||2< S, we have 
\Y{u)-Y{u)\ = Y1 r ke^^'[^Uie-^^'-''^-Vtt] ds-
j=i Jtj i-i 
^ r iteAGS[^Ae-7(s-" - vth] ds 
j=l Jtj i=l 
= i ] I r ke^GS t � U i -幼6-*, ds + 
j=l L 4 t=l 
广 ke^ GS ^ Uit-^^''^'^ - Vth c^sj (Assume that Sj > Sj) 
J” i=l 
< V r ke^GS 16e”(s-ti) ds + ^ r ke^^'[v{s) - vth] ds 
— j = i Jtj i=l j=l ^'i 
^^^ ^^^ _^^ ^^^ ^^_——^—^^^^ —^———^^^^ ^^^ ^^^ ^^^ ^^^ ^^—~«节 ¢403 
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< V r ke^GT ^ ^ ds + ^ [ ‘ ke^^^[vmax 一 Vth] ds 
—j=i Jtj i=i j=i J'j 
n 打 _ 
= ^ ke^^^j6{sj - tj) + Y^ ke^^^[vmax — Vth]{sj 一 sj) 
j=l J=1 n 
< ke^GT ( Y^ 力 At(5 + nke^^^[vmax 一 ^thVi 
j=i 
< ^ , i ! i : ^ A ^ + n W > ^ 一 m] X 2 * ‘ $ 一 灿丨 
ke^^^{n + l)T 6 e 
- 2 X ke>^ GTT{n + l) 2 
= e , 
therefore Y{u) is a continuous function ofu, and so is y{T). We have proved the 
objective function J^{u) is continuous. • 
For the later use, we need the compactness properties of the feasible set U. 
Lemma 3 U is a compact set. 
Proof: From the equation (2.3) and the constraint (2.4), we can show that, 
f o r a l l u € U , Ui < Vmax f o r a l l i. 
Assume that Ui > Vmax for some i, we have 
n 
v{ti) 二 Y,Uje-<''-'i^H[U-tj) j=i 
= i y , * t j ) j=i 
> 7iie-*td 
= Ui�Vfnax. 
This violates the constraint (2.4) and thus u 朱 U. 
So, we know that for all u € U, 0 < Ui < Vmax for all i. Thus, U is a bounded 
subset of R^. 
Next, we will prove that U is closed. 
^^^—^^^^^^^^^^^^^^^^^^^^^^^^^—^^^^^^-^^^^^^^—^^^^^^^^^^^^^——^^^^•^^^^^»^^^—»-^^--«^ 
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Assume that U is not a closed set. Then, we can find a sequence {以⑷}^  in U 
and the limit point, say u% is not in the feasible set U. That means, there is 
some j such that 
咖*) < 0. 
By continuity, we know 3 6 > 0 such that 
Qj{u) < 0 V w : II u-u* | | 2 < s, 
Since {w(i)}gi is a convergent sequence to u% there exists some w(” such that 
I u^) 一 u* ||2< 6 and thus gj(u('^) < 0. It contradicts with the definition of the 
sequence {w^'^|gi. 
Hence, U is a closed subset o f R ^ By the Generalized Heine-Borel Theorem [12]， 
we know that any closed and bounded subset ofR^ is compact. That implies the 
feasible set U is a compact set. • 
Consider the problem of minimizing (2.12) subject to equation (2.9), over u G U, 
i.e. Problem P(^0 : 
n 
min J^{u) 二 i ( T ) 一 ^ Y) u]. 
以印 t=i 
Let u^* be an optimal solution ofProblem P(/j,), and u* to be an optimal solution 
of the original Problem P. Suppose that {i/^'*} is a sequence of optimal solution 
formed by letting /x — 0, then we have 
Theorem 2 There exists a subsequence of{u^'*} which converges to an opti-
mal solution of Problem P. 
Proof: Since U is a compact subset of R", there exists a convergent subse-
quence of {w",*}, still denoted as itself. Let the limit of this sequence be w。，*. It 
remains to show that w^ '* is an optimal solution of the original Problem P. 
For every |j, > 0, 
M u n < W < Uu*) (2-14) 
.:40 
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since u^^* is an optimal solution of Problem P(") and Mu) < J2(u) for any 
feasible u. 
As U is bounded and h is continuous in u, the following holds : 
• n ] 
limJ>",*) = lim J2K'*) -ME(< '*) ' =J2(t^o,*). (2.15) " 0 … " 0 L t ^ • 
(2.14) and (2.15) imply that J2{u^^*) < J2(w*). Since u* is an optimal solution of 
Problem P, we have J2{u*) < J2(^''*). In other words, J2{u^^*) = «^以*)’ so x^°’* 
is an optimal solution of Problem P. • 
2.2.2 The Final Minimization Problem 
Summarizing the preceding sections, we formulate the complete problem to be 
considered in the thesis as follows : 
n 
min f(u) = -y{T) 一 “ V x^? (2.16) 
uGR" T^ 
t = l with differential equation : 
r y{t) = -Xavit) + k[v{t) - vth]H[v{t) 一 vth] (2 工了） 
1 y(0) 二 "0 
subject to : 
9j{u) = y f e + i ) - Vmin > 0， j 二 1，• •.，n 一 1. ( 2 . 1 8 ) 
p , + n - i { ^ ) 二 ^ c u c 一 E ¥-)('广'。> 0 , j 二 1，• • •，几‘ ( 2 . 1 9 ) 
i= l 
^2n(^) = Uc_ - - E 以《（1 一 e-7(r-k)) ^ 0 (2.20) 
7 i=l 
gj+2n = Uj > 0, j = l , . . . , n . (2.21) 
For convenience, we will simply write the system (2.16) - (2.21) as follows : 
min f{u) (2.22) 
s.t. g{u) > 0 (2.23) 
where g(u) = {gi{u), g2{u), • • •, gsn{u)V' 
^ ^ ^ ^ ^ ^ ^ ^ ^ _ _ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ _ _ _ — ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ — — — — ^ ^ ^ — r o - ” 
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2.2.3 Existence of Optimal Solutions 
Since the objective function f(u) ofthe minimization problem (2.16) is continuous 
and the feasible set U is compact. The following theorem guarantees the existence 
of an optimal solution u* to the minimization problem (2.16) - (2.21). 
Theorem 3 (Maximum and minimum value theorem) fcf. [4]) Let f ： 
X — Y be continuous, where X is a subset ofW and Y is a subset ofR. / / X 
is compact, then there exist points c and d in X such that 
f{c) < f{x) < m VxGX. 
Proof: As X is compact, X is closed and bounded. Due to the continuity of 
the function f and the boundedness of X，the infimum of the function f{x) over 
X exists. Let 
finf = inf f { x ) . 
Assume that {f{xi)}^^ be a sequence converges to finf where Xi G X for all i 
and let 
c = lim Xn. n—oo 
As closed set contains all its limit points, c is in the set X. Hence, there exists a 
point c in X such that 
f{c) = finf < f { x ) V X E X . 
Similarly, we can show that there exists a point d in X such that 
f{x) < f{d) V x E X . • 
Theorem 4 The minimization problem (2.16) - (2.21) has at least one solu-
tion. 
^^^^^^^^^^^^^^^^ —^^^^^^^^^^^^^^^^^^—~-^^^^^^^^^^^^^^^^^——^^^ —^^^^—^ "^^^^  ~' H 
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Proof: In the minimization problem (2.16) - (2.21)，the objective function 
/(w) 二 _iKT) 一 A^Er=i ^i is continuous and the feasible set U is a compact 
subset of R^. Hence, by applying Theorem 3’ we know that the minimization 
problem has at least one solution. 口 
2.3 Gradients of the Objective Function and the 
Constraints 
In order to calculate the optimal solution numerically, we have to know the gra-
dients of the objective function and the constraints. 
For the constraints, the gradients of functions f(u) and gj(u) in (2.19)，（2.20) 
and (2.21) with respect to Ui are easy to obtain. They are given by 
/9". 1 _ e _ t * 0 if i < j 
^9j+n-i 二 ^ -J j = l,.",n. 
dui 0 if i > j < 
^ = � f l _ e ” ( T-“)） 
dui 7 V / f ao-2n 1 if ^ = i - 1 
3计饥= J = l , . . . , n . 
9ui 1^  0 if i ^  j 
Next, we will focus on the derivations of the gradients of the objective function 
(2.16) and the constraint (2.18) with respect to Ui. The gradients are constructed 
in the following theorem. 
2.3.1 First Derivatives 
Theorem 5 The objective function J^ and the constraints gj, defined by equa-
tion (2.12) and (2.18), have the following analytical gradients : 
叫 二 k ^]^^l{ti-Sm)-^G{T-Sm) — y^{ti-tm)-XG{T-tm)^  _ 2^Ui (2.24) 
8ui — 7 - Ac ; ^ . 
^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ — ^ _ ^ ^ ^ ^ ^ ^ ^ — ^ — . ~ ^ -
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j 
dgj 二 - k ^r^7(ti-^m)-AG(tj+i-5m) _ g7(ti-tm)-AG(ti+l-im)] (2.25) 
^ - 7 - Ac ^ . 
for i = 1,. •., n and j 二 1, • •. ’ n - 1. 
Before giving the proof, we first introduce the Hamiltonian and costate functions 
of J2{u) in (2.11) and the nonlinear constraints (2.18). 
For convenience, let go(u) denotes the function J2(u) and gj(u) denotes the (n-l) 
constraints in (2.18)，for j = 1 , . . . , n - 1. 
Each function gj{u) has an associated Hamiltonian and costate function. The 
costate function, ^K.), is analogous to the Lagrangian multiplier used in the non-
linear programming theory. It is used to adjoin the system equations onto the 
integrand of the constraint to form a Hamiltonian : 
Hj = _ m . 
For j = 0,l,...,n 一 1，each costate function is determined by a differential 
equation of the following form : 
• 二-尝， （2.26) 
with boundary conditions : 
^ .u ) ^ _M_ (2.27) 
铺。dy{UY 、 乂 
With the above preparations, we are ready to prove Theorem 5. 
Proof: From (2.27), we have 
0 
_ = ^ y 
When j 二 0 and U = T, we have 
• = 為 
=d{-y{T)) 
-d{y{T)) 
= - 1 . (2.28) 
^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ _ ^ ^ _ — ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ — ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ — ^ — ^ r > » ~ ’ - . 
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For j = 1,. • •, n - 1 and U 二 tj+i, we have : 
条 ) 二 ^ ¾ 
_ d(y(ij+l) - ymin) 
二 ~"d{y{t^+i))~" 
= 1 . (2.29) 
The gradients can be calculated from : 
丛 二 r ^ d t (2.30) 
dui Jo oUi 
^ = r '^dt (2.31) 
dui Jo oUi 
Also, we have 
Hj ==也⑴卵). 
By differentiating both sides with respect to y, we get 
营 = _ 響 
二 • … � " + 賴 ： 爾 ) - — ) ( b y (2.9)) 
=-^G^j(i), 
or equivalently, 
- 樂 = 碰 、 , 
that is, 
••�=AcV^_^(t) for j = 0’ •..，n 一 1. (2.32) 
Using the boundary condition in (2.28) and (2.29), we can solve equation (2.32) 
and get for j = 1,2, •. •，n 一 1, 
M t ) = - e ' G ( " , (2.33) 
7fij(t) = e^G(t-t^). (2.34) 
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So, we know that 
Ho = Mt)y{t) 
二 Ac7eAG(t-r)Mf) _ e^^^'-^^k[v{t) - vth]H[v{t) - ^ ] , 
2El = _ e A G ( t - l ^ i ^ l i 7 [ r ( t ) - ^ ] dui oUi 
= _ , 6 似叫舰； 1 ¥ -『 )卯 -幼耶的 - — 
OUi 
= - k e ^ o { t - T ) ^ - j { t - u ) H ^ ^ 一 ti)H[v{t) - Vth] 
二 -j^e(Ac^-7)t+7ti-AGr^(f _ ti)H[v{t) - vth]. (2.35) 
Similarly, we have for j = 1，2,. • •, n - 1 
^ = ke^^o-i)t^iU-^Gtj^iH{t - ti)H[v{t) 一 vth]. (2.36) 
dUi 
Hence, the gradient of the J2{u) is 
T* 
^ = [ -ke^^o-^^^+iU-XaTfj^^ _ t,)H[v{t) - Vth]dt 
dui Jo 
= ^ 广 _jte(AG-7)t+7ti-Ac.T^^ 
m=i Jt^ 
7 打 
二 ^ y^(g7(ti-5m)-AG(T-Sm) — ^l{ti-tm)-XG{T-tm)^^ 7 — Ac ^ . 
‘ m=t 
which implies 
叫 _ ^ ^f^^Mti-Sm)-XG(T-Sm) 一 g7(ti"tm)-AG(T-U)) — 2|_lUi. 
8Ui — 7 - \G ；^  
The gradient of the j-th nonlinear constraint Qj, for j = 1，. • •，n - 1, is 





_ 一紀 y^/g7(^i-Sm)-AG(ti+l-Sm) 一 ^l{ti-tm)-XG{tj + l-tm)\ 
_ 7 - Ac 乙 ， 
‘ m=i 
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fori = l,...,rL 口 
In summary, the gradients ofthe objective function and the constraints are listed 
as follows : 
j n 
dJn 二 ^ y^f^^l{ti-Sm)-><G{T-Sm) — ^l{ti-tm)-XG{T-tm)^ _ 2|J,Ui. ^ _ 7 - AG ^ . 
j 
^9j 二 -k ^^^j{ti-Sm)-XG{tj+i-Sm) 一 ^j{ti-tm)-XG{tj+l-tm)^^ 1 < j < fl — 1. 
dui 7 — Ac . » ‘ ^ rn—i 
% + n - l 二 I 一已一7(力广力{) W j l < i < n . 
dUi I 0 if i > i, 
^2n 二 _ i A _ e " T ( T - t i ) y dui _ 7V / f 
^9j+2n 二 1 if、二 j 1 < j < n. ^Ui 0 i f i ^ j , k 
2.3.2 Second Derivatives 
Once we obtain the first derivatives of the objective function and the constraints, 
the second derivatives can be easily derived. We have 
T^  
叫 二 k ^ (^l{U-Sm)-XG{T-Sm) 一 ^j{ti-tm)-XG{T-tmA 一 2_ ^i - 7 - A G ^ A ) 7¾ 
d (dJ^\ 二 __^ f k ^ (^j{ti-Sm)-XG{T-Sm) 一 ^7{ti-tm)-XG{T-tm)\ 一 2^Ui 
^ i V ^ i ) — dui V7 - Ac ^ . V ) 乂 
ift—Z 
= 六 ± ( " ( “ ) 等 叫 ( - 智 + > 每 ) - 2 " £ ‘ m=i 
= - k j2 ( e 7 ( “ ) _ A - � ) ) (¾^) - 2/ig 
m=i 
_ ‘ -k El=i (e7(�-�)-AG(r-snO) (¾^ ) 一 2/i if i = 1 
— y _J^ X T _ . (67亡广石饥）-久。(了一否饥）)(¾^). if i ^ 1 
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Similarly, we have the second derivatives of the constraint functions gj ： 
For j = 1,2,. . . ， n _ 1 
j 、 
dgj 一 -k 兮(^j{ti-Sm)->^G{tj+l-Sm) _ ^l{ti-tm)-><G{tj+l-tm) 
^ 二 7 - A G ; ^ V 
d (dgj\ — d ( -k 令 f^y(ti-Sm)-><G(tj+l-^m) — g7(ii-*m)-AG(^i+l-*m)^^ 
^ v ^ / = ^ W - A c ^ A )) 
_ -k 令(^^iU-Sm)-XG{tj^.-Sm))( 一 杂 + X c ^ ) - r y _ Ar Z^ V / V dui dui / 
‘ m=i 
=k J2 ( e t ^ - ^ + i - q ) ( ¾ ^ ) . 
m=i 
For j = n, n + 1,. • •，3n, the first derivatives of the constraint functions gj are 
independent of m for any i = 1，2,.. •, n. Therefore, the second derivatives are 
zero. So we have, for j = n, n + 1,. • •, 3n 
# = 0. 
OUiOUi 
The following equations give the second derivatives of the objective function and 
the constraints : 
a % 二 f -k TTm=i (6你--)-似了-〜)驚)一 2" if i = 1 
duidui — l—fcEJJ^—(e7(*c�)-AG(T-sm)t) ifz ^ 1 
^^9j 二 j ^ f ( "e7( t i -� ) -AG�+l -Sm)�� 7二1，...，几一1. 
duidui L . V dui J ‘ * m=i 
-^ ！^  = 0 i = n,...,3n. 
duidui 
where 
0 if Sffi = tm 
dSm 0 if Sm 二 ^m+l =< 
dui 0 if 1 > m 
l e 2 ! i if / < m. 7 ET=i Wie^'» _ 
Chapter 3 
Numerical Methods for 
Minimization Problems 
In this chapter, we are going to discuss the numerical algorithms for solving the 
constrained minimization problem. We will introduce two iterative methods: La-
grangian multiplier method and Penalty function method. 
For the Lagrangian multiplier method, we will define an Augmented Lagrangian 
function of the constrained minimization problem. Then we will use Augmented 
Lagrangian algorithm to find the solution of the original constrained minimization 
problem. In the Augmented Lagrangian algorithm, we need to solve some uncon-
strained minimization subproblems, we will use the Armijo algorithm. Besides, 
we will further modify the Augmented Lagrangian algorithm and compare the 
numerical results obtained. 
For the Penalty function method, we will define a Power Penalty function of the 
constrained minimization problem. Then, we will use Newton's algorithm to solve 
the related unconstrained minimization problem. 
In the last section, we will present some numerical results and compare the per-
formance of different algorithms on the Gompertz Model. 
31 
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3.1 Lagrangian Multiplier Method 
We now introduce the Lagrangian multiplier and augmented Lagrangian methods 
for solving general constrained minimization problems. 
Consider the minimization problem : 
m i n f{u) ( 3 . 1 ) 
s.t. g{u) > 0 (3.2) 
where f : R " 一 R, g ： R^ — R^" and u ^ R". 
We denote 
g{u) 二 [“丄⑷，…’仍打⑷]、 
Definition. The Lagrangian ofthe constrained problem (3.1) 一 (3.2) is defined 
by 
L{u,X) = f{u)-X^g{u), (3.3) 
where X € R^^ is called the Lagrangian multiplier. 
With help of the Lagrangian functional, the constrained problem (3.1) - (3.2) 
can be transformed into an unconstrained problem. 
Definition. A pair {u*,X*) is called a saddle point of the Lagrangian L{u,X) 
if it satisfies 
L{u*,X) < L{u*,X*) VA € R ^ , (3.4) 
L{u*,X*)<L{u,X*) Vw€R^ . (3.5) 
Numerical Optimal Control in Cancer Chemotherapy 33 
3.1.1 Kuhn-Tucker Condition 
We now establish some optimality conditions for the saddle points of the problem 
(3.4) - (3.5). 
Theorem 6 If {u*, X*) is the saddle point to the problem (84) and (3.5)，then 
{u%X*) satisfies the following conditions : 
(1) Vn LK,A*) = 0, (3.6) 
(2) \*pAu*) = 0 Vi (3.7) 
Proof: Condition (1) is obvious due to the first order necessary conditions for 
optimal points. 
For condition (2), we let \ = sf and A| = s f , then (3.4) becomes : 
L^*(s) < Lu*{s*) VseR3^, (3.8) 
where Lu^{s) = /(ix*) - s^^g{u*), s^ = [s?, s\�..., s l ^ f . 
So, 5* will be the global maximum of the function Lu*{s). 
Thus, we have : 
dLu* n w-^ ~ 二 0 Vz, 彻 一 that is, 
-2s*gi{u*) = 0 Vi. (3.9) 
If Qi{u*) + 0，（3.9) implies 5* = 0，thus A* = 0. • 
Theorem 7 The saddle point {u*,X*) to the problem (3.4) and (3.5) is the 
optimal solution to the constrained minimization problem (2.22) - (2.23). 
Proof: Let (w*,A*) be the optimal solution to (3.4) and (3.5). That is， 
L{u\\)<L{u\\*) VAeR^� 
L{u*,X*)<L{u,X*) W€R". 
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(3.4) implies for all A > 0, 
/ K ) - A^g(u*) < f{u*) - y^g{u*). 
(A - X*fg{u*) > 0. (3.10) 
If Qi{u*) 二 0, constraint (2.23) is then satisfied. 
If Qi{u*) / 0，(3.7) implies A* = 0, (3.10) becomes 
X^g{u*) > 0 VA € RJ^, 
i.e. g{u*) > 0. 
Thus the constraint (2.23) is satisfied. 
Note that (3.5) implies for every u € U that 
f(u*) - A*^ g(u*) < f(u) - y^g{u). (3.11) 
Since (3.7) gives X*^g{u*) = 0, also, g{u) > 0 for every u £ U and A* > 0. Thus, 
(3.11) yields 
f{u*) < f{u). 
Hence, u* € U and f{u*) < f{u) Vw € U. This prove that u* is the optimal 
solution to the constrained minimization problem (2.22) - (2.23). 口 
3.1.2 Model Augmented Lagrangian Algorithm 
In the following, we present an algorithm from [6] for finding the saddle points of 
the unconstrained problem (3.4) — (3.5). 
Augmented Lagrangian Algorithm is an algorithm for finding the saddle points 
of the unconstrained problem (3.4) — (3.5). First, we define the Augmented La-
grangian Function of the Lagrangian functional (3.3): 
lA{u, A, p) = f{u) - X^g{u) + ^g{ufg{u), (3.12) 
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where 妳） = [ g M 9 M ' " . 9 i M V and 恥⑷ are the constraint functions 
with the corresponding Xy > 0. 
From the Kuhn-Tucker Condition (3.7), we have Xt9i{u*) = 0. That means at the 
saddle points, u* lies on the boundary of the feasible region for the exceptional 
case of Ai = 0 for all i. Hence, in the Augmented Lagrangian Algorithm, we are 
going to find the boundary points in each iterations. 
Let g denotes the correct set of active constraints, namely the constraints which 
corresponds to Lagrangian multiplier A^  > 0. We will use the pre-assigned active 
set strategy to determine which constraints should be included in g at each itera-
tion. The pre-assigned active set strategy is to calculate the Lagrangian multiplier 
in the previous iteration. In each iteration, with the Lagrangian multiplier, we are 
going to find the point Uk such that Uk satisfies all the active constraints g{uk) = 0. 
Before the algorithm starts, we need some initialization parameters : an initial 
selection ofthe constraints to be included in g] an initial estimate ofthe Lagrange 
multiplier, Ao； a penalty parameter p; a positive integer K, which serves as an 
upper bound on the number of iterations of the unconstrained minimizations to 
be performed; and an initial guess u^. Then set k to be 0 and start the iteration 
of the algorithm. 
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Model Augmented Lagrangian Algorithm 
(i) If Uk satisfies the optimality conditions, that is V ^ ^ K ) = •，the 
algorithm terminates with Uk as the solution. 
Otherwise if k > K, the algorithm terminates with a failure. 
(ii) With Uk as the starting point, use some iteration to solve the sub-
problem : 
min^eR" ^A{u, A^, p) 二 /(tx) - A^(n) + ^g[ufg{u), 
including safeguards to cope with unboundedness of the function 
LA{u,Xk,p)-
Let Uk^i be the best approximation to the solution of the above 
unconstrained minimization. 
(iii) Compute A^+i by 
Afc+i 二 Xk - mm{pg{uk+i), h)-
(iv) Increase p if the constraint violations at Uk+i have not decreased 
sufficiently from those at Uk. 
(v) Set k 二 k + 1, and GO TO (i). 
Remark 1 : The constraints Qi{u) corresponding to A^  is considered to be in-
active if \ = 0 and active if A^  > 0. The active constraints is denoted by g{u) 
above. 
Remark 2 : Safeguards is a very small number, when the function value is less 
than it at some iteration, stop solving the subproblem and update \k. 
Remark 3 : In our experiments to be reported in the later section, the penalty 
parameter p is kept constant and the constraint violations at Wfc+i is not justified. 
3.1.3 Armijo Algorithm 
In step (ii) of the Model Augmented Lagrangian Algorithm, we need to solve an 
unconstrained minimization subproblem. We will use the Armijo algorithm [3 
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for this purpose. 
In the Armijo algorithm, we need the following parameters and functions : 
a € ( 0 , l ) , /^€(0.5,0.8)， 0 = 1 
^(/i, u) == [lM(w + M^(w)) 一 ^A(u)] + fm II h{u) ||2 
where h{u) = — • LA{u). 
Armijo Algorithm 
(i) Set i = 0. 
(ii) Calculate h{ui) 二 一 • i^(Wi). 
(iii) If h{ui) = 0, STOP. 
(iv) Set /i 二 Q. 
(v) Calculate 6{^,Ui). 
(vi) If 0{ i^, Ui) < 0, set Ai = ", and GO TO (vii). 
Otherwise, set “ = /^", and GO TO (v). 
(vii) Set Ui+i 二 Ui + Aih{ui), and 
set i = i + 1, and GO TO (ii). 
We have the following convergence results for the Armijo Algorithm. 
Theorem 8 If the function L^(w) is bounded from below, then the Armijo 
algorithm converges and every sequence {ui} generated by Armijo algorithm is 
either finite, terminating at Uk with S/LA{uk) = 0，or it is infinite and every 
sequence {w^} has a convergent subsequence (¾}¾ such that {ui^)k ~> u and 
S7LA{u) = 0. 
Proof: Let u^ be the initial guess, and {wi)go be the sequence generated by 
the Armijo Algorithm. 
Ifthe algorithm stops in step (iii), that is, the gradient is zero, so a local minimum 
is found. 
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If not, we will have an infinite sequence {ui}^Q. 
In step (vi), 0{n,Ui) < 0 implies 
LA{ui + fih{ui)) - LA{ui) + m II h{ui) | p < 0， 
that is 
LA{ui^i) - LA{ui) < -fia II h{ui) ||2, 
thus 
LA{Ui+i) < LA{Ui). 
Hence, the sequence {L](Wi)}go is strictly decreasing. Due to the lower bound-
edness assumption, the cost function sequence converges. 
By the lower boundedness assumption and the continuity of the cost function 
LA{u), {Ui}i is bounded. Therefore by possible extracting a subsequence, we can 
assume that 
Ui ^ U, lA{Ui) ^ LA{u), 
and 
S/LA{Ui) — ylA{u), 
where u is the limit point of the sequence {^¾}¾- Next, we will show that 
s7LA{u) = 0. 
We define A : R" ~ ^ R^ as follows : 
# ) = {w' = w + _ ) I A^ 2 0 * , ? / ) ^ , 
where h{u) is defined in step (ii). 
Assume that s/LA{u) + 0. 
First, we show that there exists an e > 0 and a S < 0 such that for all u', 
I u — u' ||2 < e, 
f{u") - f{u') < 6 < 0, 
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for every u" € A{u'). 
Let ^ u ) = e{fi,u)/fi. Since V^>i(w) + 0, we have 
V^(0,fZ) = a|| h{u) f > 0. 
By continuity, there exist /x* > 0 such that t/^ (jU, u) > 0 for all /i G [0,"*]. Let 
/3(u) 二 min{VK", u) | ^i G [0, ^1} > 0. 
Since [0, fj.*] is compact and 补 is continuous, there exist e' > 0 such that for all 
u', II u - u' ||2< e', and for all |J, € [0, |J,% we have 
mfi,u)-^{fi,u')i < ^ 
你从丨、> i ^ M - ^ 
^ m 
- T 
Thus, it must be true that if u" £ A{u'), then u" = u' + pi'h{u') and n' > "*. 
Otherwise, 0{^', u') = ^i'W,u') > ^ > 0 and u" i A{v!). 
Since || h{u) [p is continuous, there exists an e" > 0 such that for all u', 
I u — u' ||2< e", we have 
II h{u') II'> \ II h{u)丨|2二 h*. £i 
Let e = min{e', e"}. Then, for all u', || u - u' ||2< e and for all u" = u' + ^Ji'h{u') € 
A[u'), we have 
0{u') < 0 
lA{u' + ^i'h{u')) - LA[u') < -fi'a II h{u') ||' 
< - " * a II h{u') ||2 
< -fjL*ah*. 
By taking S = fi*ah* > 0, we have 
LA{u") - LA{u') < -6, 
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for all u" e A{u'). 
Consider the sequence {mj^o- Since V^A(w) + 0, by the proved result, there 
exists an e > 0，a b > 0 and a k € N such that for all i > k, i € N, 
I U 一 Ui ||2< € 
and 
LA{ui+i)-LA{ui) < -6. 
Hence, for any two points Ui, Wi+i of the sequence with i > k, we have 
LA{Ui^j) 一 LA{Ui) = [LA{Ui^j) 一 LA{Ui^j-l)] + [LA{Ui^j-l) 一 LA{Ui^j-2)] + • • • 
+ [Zvl(Wi+i) — lA{Ui)] < LA{Ui^l) - LA{Ui) < -6. 
It shows that the sequence LA{ui) is not a Cauchy sequence and contradict to 
the convergence of L^(wi). Thus, SjLA{u) = 0. • 
3.1.4 Modified Augmented Lagrangian Algorithm 
Since the convergence rate of Augmented Lagrangian Algorithm depends criti-
cally on the convergence of the Lagrangian multiplier estimates, there are many 
modified augmented Lagrangian algorithms which update Lagrangian multiplier 
more frequently and more accurately [6]. In this section, we will use only one sin-
gle iteration of the Armijo Algorithm for solving the unconstrained minimization 
subproblem : 
min lA{u, Afc, p) = f{u) = Xlg{u) + ^g{ufg{u) ueR" ^ 
followed by a Lagrangian multiplier update. 
Let g denote the correct set of active constraints. We will use the pre-assigned ac-
tiye set strategy to determine which constraints are included in g at each iteration. 
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Before the algorithm starts, some initialization is made : an initial selection of 
the constraints to be included in g] an initial estimate of the Lagrange multiplier, 
Ao； a penalty parameter p; a positive integer K, which serves as an upper bound 
on the number of unconstrained minimizations to be performed; and an initial 
guess Wo. Let a, /3, p be three parameters which satisfy 
ae(0 , l ) , /^€(0.5,0.8), ^ = 1 
and 
9{yi, u) = [Zvi(w + lJih{u)) 一 LA{u)] + ^ia || h{u) ||^ 
where h{u) = — • L^(u). 
Modified Augmented Lagrangian Algorithm 
(i) Set k = 0. 
(ii) If Uk satisfies the following optimality conditions, that is, 
SjLA{uk) = 0，the algorithm terminates with Uk as the solution. 
Otherwise if k > K, the algorithm terminates with a failure. 
(iii) Calculate h{uk) 二 一 • ^M(^ f^c); 
(iv) Set jU = Q] 
(v) Calculate 外"，Uk)] 
(vi) If e{ i^, Uk) < 0, set A 二 "，and GO TO (vii); 
Otherwise, set /i = /^ "，and GO TO (v). 
{vii) Set Ufc+i = Uk + Ah{uk)] 
(viii) Compute A^+i by 
Xk+i = A f c 一 min{pg{uk+i), Xk)-
(ix) Increase p if the constraint violations at Uk+i have not decreased 
sufficiently from those at Uk. 
(x) Set k = k + 1，and GO TO (ii). 
Remark 4 : In the Modified Augmented Lagrangian Algorithm, step (iii) to 
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step (vii) is a single iteration of the Armijo Algorithm which solves the uncon-
strained subproblem on minimizing Lx(w). 
Remark 5 : Similarly as in the Model Augmented Lagrangian Algorithm, the 
penalty parameter p is kept constant for the experiments in the later section. 
Remark 6 : In this algorithm, safeguards is no longer needed as only a single 
iteration is performed in the unconstrained minimization subproblem. 
3.2 Data on the Gompertz Model 
In the following we present some basic data required for the calculations in the 
Gompertz Model [1 . 
We assume that the therapy was modelled over a period of 52 weeks with doses 
given weekly (n = 52), and that a tumour of 10^ ^ cells took 4-6 months to double 
in size and the plateau population 0 was 10^ ^ cells. In the following calculations, 
r 二 165 days was used, the growth parameter Ac may be calculated using equa-
tion (1.2). It thus follows that Ac 二 9.9 x 10"^ days_i. The initial tumour cell 
population No was 10^ ^ cells. The half-life of the drug concentration was 2.5 days 
(7 = 0.28 days-i), and the drug concentration below which no tumour cells were 
killed was Vth 二 10[D]. Here, [D] is the unit of drug concentration. The value of 
the proportion of tumour cells killed per unit time per unit drug concentration is 
k = 2 .7 X 10一2 d a y s - i [ D ] - i . 
3.2.1 Optimality of Solutions 
By performing several numerical experiments on this problem, we have found out 
that the problem still got a number of local minima lying on the boundary of 
the feasible region described by (2.18) -（2.21). Up to now, there is no method 
which can find the global optimal solution. Obviously, to run the minimization 
algorithm a number of times with different initial guesses and select the best 
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resulting solution may help to find out the optimal solution which is closer to 
the global optimal solution. However, this is computationally expensive and the 
obtained solution is still not known to be globally optimal or not. 
Consider the minimization problem (2.16) - (2.21), if we remove the constraint 
(2.18), the following theorem give us a global optimal solution to the problem [1 • 
We first define a function vi(t). Let tq be some dose time and for any U satisfying 
0 < ti < tq, Vi{t) = Vmaxe^^^-^'^ for t £ [ti,U+i). 
Lemma 4 (cf. [1]) If 
/ t q + l r*P+l 
Vi{t)dt> J^ V2{t)dt, 
then for any V2{t) satisfying (2.3) and (2.19), 
/t^+i rVfi 
v i [ t ) 一 Vth]H[vi{t) 一 Vth] dt > y� [v2{t) - Vth]H[v2{t) - Vth] dt. 
Lemma 5 (cf. [1]) Suppose that tq < tp and 
I : fi{s)H{h{s)) ds > I : f2{s)H{f2{s)) ds, 
where fi{s) 二 ;^i(s) - Vth and f2{s) = ；^2(^  一 Vth. Then for any v2{t) satisfying 
(2.3) and (2.19), 
j : Ms)H(Ms))e-XG(tfS)而 > 1 : f2{s)H{f2{s))e-'-^'^-^^ ds. 
Before giving the major theorem, we first define a control function v*{t) as follows: 
' 0 , for t < T - tq , 川 、 v*{t) = (3.13) I Vmax, for each U satisfying T - tq < U < T, 
and 
/V*{s) ds = i>cum. 
-
Note that the a s s u m p t i o n on v* saturating the cumulative drug toxicity constraint 
(2.20), can always be satisfied with just a small change to Vcum which is only an 
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estimation of the cumulative drug toxicity. 
Let u* be the parameter vector uniquely defined by the function t;* as follows : 
, u*{U) 二 0, V 0 < U < T - tq 
< u*{T-tq) 二 ^；脳0：, (3.14) 
U*{U) = Vma.-��xe-*, V T - t, < u < T. 
< 
Under the above construction of u% it is obvious that v*{t) = 0 for all t < T - tq 
and v*{T - tq) = Vmax- Let us consider v*{T - tq + At): 
V*{T 一 t, + At) = J2 %*e-7(T-e"+AM)F(T — tq + M - t j ) 
i=i 
= = n * ( r - t g ) e + � + _ - ' g ) ) 
+u*(T - tq + At)e-^(T-t,+^t-iT-u^At)) 
=We-W + {Vma. - W e - * ) • 1 
— ^max. 
Similarly, we can show that v*{ti) = Vmax for all T - tq < U < T. 
Theorem 9 The parameter vector u*, as defined by equation (3.14), is a global 
optimal solution of the problem defined by (2.16), (2,17), (2.19), (2.20) and 
(2.21). 
Proof: From equation (2.10), we have 
y{T) = yoe-^^^ + e-^GT f e^^'k[v{s) - Vth]H[v{s) _ Vth]ds 
Jo T* 
=yoe-^^^ + k [ b(s)-i^]Fb(5)-t^]e-AG(r-�5. 
Jo 
Since u == [W1,W2, •..，Wn] is not a function of t, we can write 
fT 
max y{T) = y^e-^^^ + max k / [v{s) - vth]H[v{s) - Vth]e-^^^^-'^ds. w ^ Jo 
From the definition of the control function v*{t), we have 
Vaum= fTv*(S)ds= ^ V*{s) ds= [\*{s^T-tg) ds. 
J o JT-tq J o 
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Also, for any V2(t) satisfying (2.20), 
rtp fT 
/ V2(s)ds < / V2(s)ds 
fk 
< Vaam= / V*{s + T - t q ) d s . Jo 
Hence, v*{t) satisfies the conditions on vi{t) in Lemma 1 and Lemma 2. By taking 
tp = T, ^;i(5) = v*{s + T - tq), fi{s) = Vi{s) - Vth and f2{s) 二 ^；2(力 一 Vth in both 
Lemmas, we have, for any v{s) satisfying (2.3), (2.19) and (2.20)，v*{t) maximize 
f^v(s) ds, then by Lemma 1 and 2，v*(t) maximize /0^[i;(5) - VthJH[v(s) - Vth] ds 
and v*{t) maximize /^^[^；(^) 一 Vth]H[v{s) 一 Vth]e-^^^^-'^ ds. 
Thus, the parameter vector u*, as defined by equation (3.13) is a global optimal 
solution ofthe problem defined by (2.16), (2.17), (2.19), (2.20) and (2.21). • 
3.3 Numerical Results 
In this section, we will demonstrate two numerical experiments, one using the 
Model augmented Lagrangian algorithm, the other using the modified augmented 
Lagrangian algorithm. In the first experiment, the exact solution can be given an-
alytically as done in the previous subsection. But we will also solve it numerically 
by using both Model augmented Lagrangian algorithm and modified augmented 
Lagrangian algorithm to compare their performance. In the second experiment, 
we will use modified augmented Lagrangian algorithm. After that, we will intro-
duce one more algorithm on solving constrained minimization problem and use 
it in the second experiment. After performing several numerical experiments, we 
will analyze the performance of different algorithms on this particular constrained 
minimization problem in the last subsection. 
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Experiment 1 : Consider the constrained minimization problem described by 
(2.16) - (2.21), with the basic data from section 3.2 and some parameter in the 
constraints given as follows : 
The maximum tumour cell population Nmax : ^ 二 10^ 2 
The maximum drug concentration Vmax : 50[D 
The maximum tolerable cumulative toxicity Vcum : 4.1 x 10^[D 
In fact, this problem is the same as the problem described in Theorem 9. As the 
cell population can never exceed the plateau population 6 二 lQi2, the constraint 
(2.18) is always satisfied. Hence by Theorem 9, one can find the analytical for-
mula of the global optimal solution. The exact solution is plotted below : 
Global optimal solu1ion lor Experiment 1 
I 1 1 1 1 1 1 r - 1 < ‘ 
3 
. I I I I I i _ • » 
0 5 10 15 20 25 30 35 40 45 50 
Time fai weeks 
Fig 3.1: Global optimal solution of Experiment 1 from the analytical formula in 
the previous subsection. 
We will use the Model Augmented Lagrangian Algorithm and the Modified Aug-
mented Lagrangian Algorithm to find the optimal solution numerically. Then we 
will compare the performance of the two algorithms which discussed in the last 
subsection. 
^^^_^^^^_ -^^^^^^^^^^^—^^^^^^^^^^^^^^^^^^^M^^^M^^^^^^^^M^^^^M^^^^^M^^^^^^^^^^^^^^^^^^^M^—^^^^™^—^^—^M^»^—^^—^M^M^MMn^M^maaa—MMBl>T»M>«<»<M»/a f . . j y :» tTM>-^ -T»»^»«>^J f l ^ ^ l f ^11T W lT : tTJl4 
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Model Augmented Lagrangian Algorithm 
Parameters in the Model Augmented Lagrangian algorithm are given as follows : 
The safeguards : _200; 
The penalty parameter : P = 1 x 10 3; 
The upper bound on the number of iterations : K = 10000; 
The initial guess :以。二 [•，•, •. •,…了； 
The initial estimate of the Lagrange multiplier : A = [1，1，• • •，1]^  
Parameters in the Armijo algorithm are : 
o; = lxlO-3, p = Q.8, 0二1‘ 
The stopping condition for the algorithm in step (i) is : 
II v i ^ K ) ll2< 10-2. 
The following figures are the numerical results of Experiment 1 by using Model 
Augmented Lagrangian algorithm. 
Number ol Heralions^1496 NumbefolHerations = 2005 
80| "T^ 1 T 1 1 1 1 1 ‘ ‘ I ‘ ‘ ‘ “ ~ ‘ ‘ ‘ • ‘ _ ‘ I 5o[* .||||g I 
的 |ri|dM 4oL jimi|||||_|||__ J 40 .MrtiiHiiiiiiMBi 1^ iUniiiHinii_iiiiiiiiiff I j jd • • _ i 4 J l l l l l l l 'Lw^  k ,____i*^  
� _ , � " B 
0^; 5 S^ l5 M M M ^ 40 45 S0““ '^0 5 10 15 20 25 30 35 40 45 50 
Time h weeks Time in weeks 
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Modified Augmented Lagrangian Algorithm 
Parameters in the Modified Augmented Lagrangian algorithm are given as 
follows : 
The penalty parameter : P 二 5 x 10 ;^ 
The upper bound on the number of iterations : K = 10000; 
^ fjn 
The initial guess : ^o = [0,0,---,0J ； 
r *i 1T 
The initial estimate of the Lagrange multiplier : A 二 [1,1, •. •，lJ . 
The parameters needed in the Armijo algorithm are : 
a = lxlO_3, p = 0.8, 0=1. 
The stopping condition for the algorithm in step (i) is : 
II v ^ ^ K ) I l 2 < 1 0 - 2 . 
The following figures are the numerical results of Experiment 1 by using Modified 
Augmented Lagrangian algorithm. 
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From the numerical results above, we see that both algorithms give the same 
optimal result on Experiment 1, the resulting objective function value -y{T) � 
-59.4477 and by using the equation 
" � � l n O , 
the final cell population after the medical treatment is reduced to N{T)= 
1.5212 X 10—14, below a single cell. 
But in most applications, we can not neglect the constraint (2.18). However, 
the optimal value without the constraint (2.18) can be treated as a lower bound 
on any solution to the minimization problem (2.16) - (2.21). As described in 
section 3.2.1，there is no any existing method which can find a global optimal so-
lution. But the lower bound provides a way of searching the optimal solution to 
the minimization problem (2.16) — (2.21). By solving the minimization problem 
numerically, if the resulting value of the objective function (2.16) is close to the 
lower bound here, that means if the resulting objective function value -y{T) is 
close to -59.4477, it must be a close approximation to a global optimal solution 
of the minimization problem (2.16) - (2.21). 
Experiment 2 : Consider the constrained minimization problem described by 
(2.16) - (2.21), with the fundamental data from section 3.2 and some parameter 
in the constraints given as follows : 
The maximum tumour cell population Nmax : 10 °^ 
The maximum drug concentration Vmax : 50[D 
The maximum tolerable cumulative toxicity Vaum : 4.1 x 10^[D 
For this experiment, we use the Modified Augmented Lagrangian Algorithm to 
find the solution numerically. 
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The resulting objective function value calculated from the optimal solution is 
_y(T) 二 -58.7741 and N{T) = 2.9835 x 10—14, which is very close to the lower 
bound given in Experiment 1. Hence, the resulting optimal solution is a close 
approximation to the global optimal solution. 
Using the numerical results, we can see the growth of the tumour size versus time: 
10^°t I I I I I \ 1 — ~ ‘ ‘ ‘ ^ r ^ n 
r � \ • 
|i。s「 \ ， ^oV \ :I \ : 
1。0 1^  I I • • I I U J I 1 I ~ 
0 5 10 15 20 25 30 35 40 45 50 
Time in weeks 
Fig 3.6: Tumour size versus time for a medical treatment of cancer with the drug 
schedule indicated in the previous numerical result. With this optimal treatment, 
the final cell population is reduced to below a single cell. 
3.4 Well-Conditioned Penalty Function Method 
for Constrained Optimization 
In the last section, we have discussed the Model augmented Lagrangian algorithm 
and the modified augmented Lagrangian algorithm. Both algorithms converge to 
the optimal solution but converge very slow. We now propose another method 
which converges much faster than the previous two methods. 
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Consider the following constrained minimization problem : 
min f{u) (3.15) 
s.t. gi{u) < 0 Vi = l,2，...，m. (3.16) 
Definition. The Power penalty function ofthe constrained problem (3.15)-
(3.16) is defined by 
m 
L{u, p) 二 /(t/) + pE[max(0 ,^W)]* (3.17) 
i=l 
where p > 0 is very large and k > 2. 
With the definition of the power penalty function, we obtain the following uncon-
strained problem which is closely related to the constrained minimization problem 
(3.15) - (3.16). 
min L(u,p). (3.18) ueK^ 
It has been proved that, u{p) — u* as p — oo, where u{p) is a solution to the 
minimization problem (3.18) with fixed p and u* is the solution to the problem 
(3.15) - (3.16). 
Before the algorithm starts, some initialization parameters are needed. An initial 
penalty parameter p; a positive integer K, which serves as an upper bound on the 
iteration number of unconstrained minimizations to be performed; and an initial 
guess UQ. Then set k to be 0 and start the iterations of the algorithm. 
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Penalty Function Algorithm 
(i) If Uk satisfies the following stopping criterion : 
[S/uL{u, p)n^LL{u, p)]-i Vn L{u, p) < 10-16, 
the algorithm terminates with Uk as the solution. 
If k > K, the algorithm terminates with a failure. 
(ii) With Uk as the starting point, execute Newton's Algorithm to solve 
the subproblem : 
min^eRn L{u, p). 
(iii) Increase p by 
p = p X 10. 
(iv) Set k = k + 1, and GO TO (i). 
Newton,s Algorithm 
(i) If Ui satisfies the following optimality conditions, that is 
•uL(w，p) = 0，the algorithm terminates. 
(ii) Calculate sjuL{u,p). 
(iii) Calculate yl^L{u, p). 
(iv) Solve p 二 - v L L�u, p ” Vw H% p). 
(v) Set Ui+i = Ui + p. 
(vi) Set i = i + 1, and GO TO (i). 
In Newton's algorithm, an algebraic system with coefficient matrix \j\^L{u, p) 
needs to solve for the search direction p. However, the system is ill-conditioned as 
p — 00. The following procedure [9] will show how to solve for the search direc-
tion p in a well-conditioned system when p ^ oo. We first analyze the structure 
of S7luL{u,p). 
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Let H = s7luL{u, p), then we have 
m 
H 二 vLfW + P&I^[max(0,"i(w))]"-ivL("iW) 
i=l 
m 
+f)k(k - 1) ^[max(0,^i(w))]^-^(Vn^i(^))(Vn^i(^^)f 




F i = V L / M + pkJ2[m8ix(0,gi{u))]'-' v L (9i{u)) 




As H2 is positive semi-definite, there exists a square matrix U such that H2 = 




\ / mxm 
where V is unitary, Y is a permutation matrix and R is a s x m matrix with 
rank{R) = s. Then, we have 
T ( RRT 0 \ V^H2V = . 
V 0 0 / \ / m x m 
With the unitary matrix V and letting 
V^H,V = I ^''路、. 
Y Z21 ^22 J 
Then, we get 
V^HV = V^HiV + pk{k - l)V^H2V 
_ ‘ pk{k - l)RRT + Zii Zl \ 
� ^21 ^22 J 
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Since H is positive definite, so is Z22. Define 
( L 0 \ 
w= _i , 
�-^2^^21 Im-s j 
which is an invertible m x m matrix. 
Then, we have 
^ ^ ( pk{k - l)G 0 \ W^V^HVW = “ V 
\ 0 Z22 
where G = RR^ + j j ^ { Z n - ^ ^ 1 ¾ ^ ¾ ) is a s x s matrix. 
In Newton's algorithm, solving the system Hp = 一 Vu L is equivalent as solving 
the following system 
{W^V^HVW){W-^V^p) 二 - T ^ r y T V u 1 
By defining 
q = W-^V^p, 
r = W^V^ S7u L. 
Then, the above system becomes 
(pk(k - l)G 0 \ 
Q = 一广 
\ 0 ^2 / 
That is equivalent to solving the following system 
f 
pk{k — l)G^'i = -ri, 
\ Z22q2 = -^2, 
, ( . A d ( r A where q = and r = I • 
V 收 / \ h ) 
Thus, the system is not ill-conditioned as p — 00. 
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Consider the constrained minimization problem (2.16) - (2.21). In order to be of 
the form as in (3.15) - (3.16), we multiply all the constraints by - 1 . The problem 
becomes, „ ‘ n 
min f{u) = -y{T) - f iY^u^ i 
奴 讯 " 1^ 
with differential equation : 
r y{t) = -XGV{t) + k[v{t) - Vth]H[v{t) - vthl 
1 y(0) = "0， 
subject to : 
9j{u) = Vmin 一 y{tj^i) < 0, j = 1, • • •, n - 1. 
3 
9j^n-i{u) = Y . ine-*ti) - Vma. < 0， j = h .. •, n. 
i = l 
92n{u) = - Y1 Ui{l - 6香叫 一 ^ ;_ < 0 
^ i=l 
9j+2n = -Uj < 0， j = l，".,n. 
Now, we solve the constrained minimization problem in Experiment 2 using 
Penalty Function Algorithm. 
Penalty Function Algorithm 
Parameters in the Penalty Function algorithm : 
The initial penalty parameter : p = 100; 
The upper bound on the number of iterations : K = 10000; 
The initial guess ： wo = u^^^] 
_ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^WWBfffWWWlfWBIWBB^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ MME3ELLiLiiiUfcaaaMHBi^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^B HMWffMfl B B i ^^^^^^^^^^^^^^^^^mi^gi^iQ^^K^^^Qiii^^^ng^^^^nQ^^^^^n2n^^^^^^^^n^^^^mi^^m^iiiiii^^mi^^i^^^^^i^^^^^^^^^l ^^^^^^^^^^^^^^^^^^^^^^^^m^^m^^m^^Q2^^^^^^m^^m^^m^^m^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ 
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^M — 
•••_濕議 
^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ i ^ ^ ^ ^ ^ ^ ^ ^ ^ m u j i m j ^ j j ^ ^ j ^ j 
^ ^ ^ ^ ^ H ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ H H ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ | 
• • 
^^^^^^^^^^^^^^BgB^mgiBSiii^ll^^^Bl^9^^m^^B3H^^^^^bHI^^^D^HSI^BHISHIS^H^^H^^^BH^H^^^^^I ^^^^^^^^^^^^^^^^^^^^^m^^m^^m^^Qg^^^^^^n^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ 
^ ^ ^ ^ ^ ^ ^ ^ H M ^ ^ I ^ B B ^ ^ ^ H H ^ | ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ Q ^ ^ | 
m 
^^^^^^^^^^^^^^^hn^^^iQiB[3ii^^niQiniggiii^n^^B^^^^i^^^9^^^i^^^i9i^^]mQiii§^^^3^^^BQiii^3^^^^^^l ^^^^^^^^^^^^^^^^^^^H^^m^^m^^m^^Q^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ 
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Fig 3.8: Results of Experiment 2 by Penalty Function algorithm. 
In the penalty function algorithm, we use Newton's algorithm to solve the mini-
mization subproblem for each fixed p. The number of iterations shown in figure 
3.8 is the accumulative iteration number within the Newton's algorithm. 
In this experiment, it takes 2000 iterations and 346 minutes cpu time to obtain 
the initial guess w^ °^® from the modified augmented Lagrangian algorithm and 57 
iterations and 6 minutes cpu time for the penalty function algorithm. 
The resulting objective function value calculated from the computed solution is 
-y{T) 二 -49.7976 and N{T) = 2.3615 x lO—i�. By comparing with the lower 
bound given in Experiment 1, it is not too close to the global optimal solution, 
but the cell population reaches the expected level, less than a single cell. 
3.5 Discussion 
In the previous sections, we have introduced Model augmented Lagrangian algo-
rithm, modified augmented Lagrangian algorithm and penalty function algorithm 
on solving the constrained minimization problem in cancer chemotherapy. Several 
numerical experiments have be performed by using different algorithms. In this 
section, we will summarize and compare the performance of different algorithms 
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for solving this particular optimal control problem. 
3.5.1 Model Augmented Lagrangian Algorithm and Mod-
ifled Augmented Lagrangian Algorithm 
In the first experiment, we have used both Model augmented Lagrangian algo-
rithm and modified augmented Lagrangian algorithm to solve the constrained 
minimization problem. It takes less number of iterations but longer cpu time 
for the modified augmented Lagrangian algorithm to reach the optimal solution. 
However, the most difficult task in the implementation of the augmented La-
grangian algorithm is to find out the suitable choice of the penalty parameter p. 
It is known that the penalty parameter p cannot be too-large or too-small [6 . 
For the Model augmented Lagrangian algorithm, optimal solution can be found 
when p = 1 X 10"^ while it fails to give the optimal solution when p = 1 x 10—4 
and p 二 1 X 10-2. 
For the modified augmented Lagrangian algorithm, optimal solution can be found 
when the penalty parameter is in the range of 5 x 10"^ < p < 5. The only dif-
ference of using a larger value of p is that it takes more iterations to converge to 
the optimal solution. 
Hence, in this experiment, it is easier to find out the suitable penalty parameter 
p by using the modified augmented Lagrangian algorithm. 
3.5.2 Modified Augmented Lagrangian Algorithm and Penalty 
Function Algorithm 
In the second experiment, we have used both modified augmented Lagrangian 
algorithm and penalty function algorithm to solve the constrained minimization 
problem. In the modified augmented Lagrangian algorithm, Armijo algorithm is 
used in solving the unconstrained minimization subproblem and Newton's algo-
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rithm is used in the penalty function algorithm. 
In the penalty function algorithm, we use an initial guess uo which is close to the 
optimal solution as described in the previous section. From the numerical ex-
periment, we know that the convergence of this algorithm is very fast as it takes 
only 57 iterations to converge. However, the solution found is not the global 
optimal solution, but the final results are acceptable. This may be due to the 
choice of algorithm used in solving the unconstrained minimization subproblem. 
In the penalty function algorithm, Newton's algorithm is used in solving the un-
constrained minimization subproblem. Hence, this may improve the convergence 
rate comparing with the modified augmented Lagrangian algorithm where Armijo 
algorithm is used for solving the unconstrained minimization subproblem. 
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